235 related articles for article (PubMed ID: 33058474)
21. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
[TBL] [Abstract][Full Text] [Related]
22. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.
Bennett CM; Neunert C; Grace RF; Buchanan G; Imbach P; Vesely SK; Kuhne T
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792679
[TBL] [Abstract][Full Text] [Related]
23. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
24. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
[TBL] [Abstract][Full Text] [Related]
25. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.
Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA;
Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life in children with newly diagnosed immune thrombocytopenia.
Heitink-Pollé KM; Haverman L; Annink KV; Schep SJ; de Haas M; Bruin MC
Haematologica; 2014 Sep; 99(9):1525-31. PubMed ID: 24951468
[TBL] [Abstract][Full Text] [Related]
27. Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia.
Li N; Mahamad S; Parpia S; Iorio A; Foroutan F; Heddle NM; Hsia CC; Sholzberg M; Rimmer E; Shivakumar S; Sun HL; Refaei M; Hamm C; Arnold DM
J Thromb Haemost; 2022 Dec; 20(12):2988-2997. PubMed ID: 36121734
[TBL] [Abstract][Full Text] [Related]
28. Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study.
Huang QS; Zhu XL; Qu QY; Liu X; Zhang GC; Su Y; Chen Q; Liu FQ; Sun XY; Liang MY; Liu Y; Jiang M; Liu H; Feng R; Yao HX; Zhang L; Qian SX; Yang TH; Zhang JY; Shen XL; Yang LH; Hu JD; Huang RW; Jiang ZX; Wang JW; Zhang HY; Xiao Z; Zhan SY; Liu HX; Chang YJ; Jiang Q; Jiang H; Lu J; Xu LP; Zhang XH; Yin CH; Wang JL; Huang XJ; Zhang XH
Am J Hematol; 2021 May; 96(5):561-570. PubMed ID: 33606900
[TBL] [Abstract][Full Text] [Related]
29. Prognostic variables in newly diagnosed childhood immune thrombocytopenia.
Ahmed S; Siddiqui AK; Shahid RK; Kimpo M; Sison CP; Hoffman MA
Am J Hematol; 2004 Dec; 77(4):358-62. PubMed ID: 15551294
[TBL] [Abstract][Full Text] [Related]
30. [Clinical Analysis of Hospitalized Children with Primary Immune Thrombocytopenia].
Li RW; Fu RF; Chen YF; Liu W; Xue F; Li HY; Zhang L; Yang RC; Liu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):574-580. PubMed ID: 33812433
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
[TBL] [Abstract][Full Text] [Related]
32. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
[TBL] [Abstract][Full Text] [Related]
33. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis.
Heitink-Pollé KM; Nijsten J; Boonacker CW; de Haas M; Bruin MC
Blood; 2014 Nov; 124(22):3295-307. PubMed ID: 25305206
[TBL] [Abstract][Full Text] [Related]
34. Excessive expressions of T cell activation markers in pediatric immune thrombocytopenia.
Chen Y; Zhou Y; Chen P; Zhang P; Jia M; Tang Y
Thromb Res; 2019 Aug; 180():1-9. PubMed ID: 31146120
[TBL] [Abstract][Full Text] [Related]
35. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].
Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H
Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.
Adly AA; Ragab IA; Ismail EA; Farahat MM
Platelets; 2015; 26(7):645-50. PubMed ID: 25350586
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
Higashide Y; Hori T; Yoto Y; Kabutoya H; Honjo S; Sakai Y; Nojima M; Yoda M; Yamamoto M; Tsutsumi H
Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
[TBL] [Abstract][Full Text] [Related]
39. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).
Imbach P; Kühne T; Müller D; Berchtold W; Zimmerman S; Elalfy M; Buchanan GR
Pediatr Blood Cancer; 2006 Mar; 46(3):351-6. PubMed ID: 16086422
[TBL] [Abstract][Full Text] [Related]
40. Contemporary management of primary immune thrombocytopenia in adults.
Lakshmanan S; Cuker A
J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
